MOLGORA, MARTINA,GARLANDA, CECILIA,BONAVITA, EDUARDO,MANTOVANI, ALBERTO
申请号：
IT201700120699
公开号：
IT201700120699A1
申请日:
2017.10.24
申请国别(地区):
IT
年份:
2019
代理人:
摘要：
The present invention refers to a stably or transiently IL-1R8 deficient isolated human cell, being a natural killer (NK) cell or T cell and to their medical use, preferably in the treatment of tumours and infections.
